CDSCO issues notice regarding review of regulatory regime for drug approval.
Medical devices will, under the new Rules, be classified as per Global Harmonisation Task Force (GHTF) practice, based on associated risks, into Class A (low risk), Class B (low moderate risk), Class C (moderate high risk) and Class D (high risk). The manufacturers of medical devices will be required to meet risk proportionate regulatory requirements that have been specified in the Rules and are based on best international practices.
DGFT extends the date for mandatory electronic filing of Non-preferential CoO to 31st October 2021.
Based on the request of certain Chambers/Associations notified under Appendix-2E, the existing system of manual/paper-based submission and processing of non-preferential CoO applications is being extended further upto 31st October 2021 only and the online system is not being made mandatory
GSTN issues advisory for taxpayers on Form GSTR-2B.
GSTR-2B is a static statement and is made available for each month on the 14 th day of the succeeding month. For example, for the month of July 2020, the statement was generated and made available to the registered person on 14 th August 2020. Details of all the documents in GSTR-2B is made available online as well as through download facility.
The Food Safety and Standards (Food Products Standards and Food Additives) Amendment Regulations, 2021.
Through this amendment, under regulation 2.5 which deals with standards for meat and meat products, the term extenders’ and ‘binders’has been defined.
Enforcement drive to check adulteration of Black Salt
In case there is any prima facie indication of any adulteration/malpractice in the production and/or sale of black salt in the premises/market, suitable necessary action as deemed fit may be initiated against the defaulting FBO.
SEBI clarification regarding transmission of Securities to joint Holder(s)
RTAs are advised to comply with provisions of the Companies Act 2013 and transmit securities in favour of surviving Joint holder(s), in the event of demise of one or more joint holder(s), provided that there is nothing contrary to the same in the Article of Association of the company.
